About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 379   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Incidence of endophthalmitis after intravitreal bevacizumab using aliquots prepared On-site in 2 operating rooms in Kuwait

Wani Vivek B, Al-Kandari Jamal, Sabti Khalid, Aljassar Faisal, Qali Hussain, Kumar Niranjan, Uboweja Anilkumar, Al-Sabah Khalid, Diab Fahad A, Al-Rashidi Saleh

Year : 2016| Volume: 23| Issue : 1 | Page no: 64-70

   This article has been cited by
1 Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings
Tong Li, Junran Sun, Jingyu Min, Shuangwen Zhou, Xiaolin Zhu, Huixun Jia, Xiaodong Sun
JAMA Ophthalmology. 2021; 139(10): 1080
[Pubmed]  [Google Scholar] [DOI]
2 Outcomes of three intravitreal injections of bevacizumab given monthly for diabetic macular oedema is a viable treatment for an economically disadvantaged population
Aazambir S. Brar, Vivek B. Wani, Arvind L. Tenagi
African Vision and Eye Health. 2021; 80(1)
[Pubmed]  [Google Scholar] [DOI]
3 Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
Nasir Ahmed, Hafeez Ur Rehman, Memoona Rafique, Muhammad S Hamza, Huma A Mirza
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
Andrzej Grzybowski, Reinhard Told, Stefan Sacu, Francesco Bandello, Elad Moisseiev, Anat Loewenstein, Ursula Schmidt-Erfurth
Ophthalmologica. 2018; 239(4): 181
[Pubmed]  [Google Scholar] [DOI]
5 Bevacizumab
Reactions Weekly. 2016; 1592(1): 47
[Pubmed]  [Google Scholar] [DOI]


Read this article